Hossam El Benawi: Do Current Generation CEPD Devices Reduce the Risk of any Stroke During TAVR?
Hossam El Benawi, Senior Clinical Research Fellow of Cardiovascular Medicine at Mayo Clinic, shared a post on LinkedIn about a recent article published in American Heart Journal, co-authored by him and his colleagues, adding:
“Current generation CEPD devices during TAVR did not significantly reduce the risk of any stroke, disabling stroke, or all-cause mortality.
Our analysis, Studies included: 8 RCTs (5 filter-based, 3 shield-based), totaling 11,597 patients:
- Any stroke: No reduction with CEPD (RR 0.92; 95% CI 0.75–1.14)
- Disabling stroke: No significant difference (RR 0.80; 95% CI 0.55–1.15)
- MRI-detected lesions: No effect (RR 1.00; 95% CI 0.93–1.07)
- All-cause mortality: No significant difference (RR 1.04; 95% CI 0.71–1.51)
- Trial sequential analysis: Demonstrated conclusive evidence, supporting no benefit of Current generation CEPD.
- Meta-regression: No significant association between stroke risk and patient-level factors (age, sex, diabetes, prior stroke, atrial fibrillation; all p > 0.05)
At least with available data, cumulative evidence appears sufficient to question the predefined benefit thresholds for existing systems.
These findings suggest the lack of routine use of current-generation CEPD in TAVR.”
Title: Cerebral Embolic Protection Devices for Transcatheter Aortic Valve Replacement: A Meta-Analysis and Trial Sequential Analysis
Authors: Hossam Elbenawi, Ibrahim Hassan, Mahmoud Shaaban Abdelgalil, Mariam Hanna, Salma Almotawally, Mahmoud Fayed, Kareem A. Mohamed, Hossam Elnaggar, Louna Abouainain, Belal Mohamed Hamed, Ahmed Ibrahim, Ahmed Al Khatib, Mohamed Elhelw, Ehab Hassan, Mahmoud Eisa, Morad Zaaya, Ramzi Ibrahim, Andrew M. Goldsweig, Marwan Saad, Fernando Alfonso, Mohamad Alkhouli, Islam Y. Elgendy
More posts featuring Hossam El Benawi on Hemostasis Today.
-
Apr 27, 2026, 13:45Sanjay Ahuja: The Hidden Financial and Human Cost of Undiagnosed Bleeding Disorders in Women
-
Apr 27, 2026, 13:42Brian A Beh: Lived Experience Is The Missing Evidence in Stroke Research
-
Apr 27, 2026, 13:36Mital Jhaveri: The Promise of Factor XI Inhibitors in Chronic Kidney Disease
-
Apr 27, 2026, 13:25Oluwafemi Ajibola: Why Understanding Circulatory Disorders of the Liver is Essential for Real Clinical Decision-Making
-
Apr 27, 2026, 13:24Karachi Advocates for Change at WFH Global Congress 2026 – Hemophilia Welfare Society Karachi Pakistan
-
Apr 27, 2026, 13:12Mohamed Isam Sharif: Happy to Have Abstract Presentation at the University of Toronto Hematology Academic Day
-
Apr 27, 2026, 13:10Elvira Grandone: Sex Differences Matter in the Management of Cancer-Associated Thrombosis
-
Apr 27, 2026, 13:07Vadim Nobel: Assessing AI Performance in Real-World Clinical Tasks
-
Apr 27, 2026, 12:57Nuuman M. Kinyasi: Tanzania’s Voice at WFH Congress 2026 – One Nation, One Global Family